Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell
Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell death.
The two companies hope to optimize techniques and instrumentation for using Apomate, an investigational in vivo nuclear medicine imaging agent that targets cells undergoing apoptosis or necrosis. Theseus will provide images and other data from its cardiac imaging trials of Apomate to Philips. Apomate images will be fused with images taken using thallium. The collaboration may result in methods that enhance Apomate imaging, leading to increased clinical acceptance and improved clinical outcomes when Apomate imaging is applied.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.